Skip to main content (Press Enter).
Sign in
Skip auxiliary navigation (Press Enter).
Contact Us
Code of Conduct
Back to ONS
Skip main navigation (Press Enter).
Toggle navigation
Search Options
Home
Newsletters
Community
Outreach
Resources
Discussion
Resources
Events
Our Events
National Calendar
Directory
Chapter Leadership
Scholarship Opportunities
TECENTRIQ: FIRST FDA-APPROVED ADJUVANT CANCER IMMUNOTHERAPY FOR STAGE II TO IIIA PD-L1+ NSCLC
When:
Sep 8, 2022 from 17:30 to 20:00 (ET)
Associated with
North Carolina Triangle
Location
Bin 54
1201 Raleigh Rd
Chapel Hill, NC 27517
Download to Your Calendar
Copyright 2017 Oncology Nursing Society. All rights reserved.
Powered by Higher Logic
×
Community Tags
Add a tag
x
User Tags may not contain the following characters: @ # $ & :